Anti-inflammatory activity of 2,4, 6-trihydroxy-alpha-p-methoxyphenyl-acetophenone (compound D-58)

Area of Science:

• Dermatology
• Pharmacology
• Biochemistry

Background:

• Ultraviolet B (UVB) radiation triggers inflammatory responses in skin cells.
• Prostaglandin E(2) (PGE(2)), a key inflammatory mediator, is regulated by active oxygen radicals and protein tyrosine kinases.
• Identifying compounds that inhibit these pathways is crucial for developing anti-inflammatory agents.

Purpose of the Study:

• To evaluate the anti-inflammatory effects of compound D-58, a novel genistein analog with antioxidant properties.
• To investigate the impact of compound D-58 on UVB-induced inflammatory responses in skin.

Main Methods:

• In vitro studies involved irradiating epidermal cell cultures with UVB in the presence and absence of compound D-58, measuring PGE(2) release via ELISA.
• In vivo studies utilized mice, inducing skin inflammation through carrageenan or UVB exposure.
• Assessed inflammatory mediator release, skin edema, and histological changes in mice treated with compound D-58.

Main Results:

• Compound D-58 significantly inhibited UVB-induced edema and histological skin alterations in mice.
• The compound effectively suppressed PGE(2) release both in vitro and in vivo.
• Demonstrated potent inhibition of inflammatory responses triggered by UVB radiation.

Conclusions:

• Compound D-58 exhibits significant anti-inflammatory properties.
• The genistein analog, 2,4,6-trihydroxy-alpha-p-methoxyphenylacetophenone (compound D-58), is a promising candidate for managing UVB-induced skin inflammation.